Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy
Clinical trial NCT01077518 · TERMINATED
Trial details
- NCT number
- NCT01077518
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-26
- Primary completion
- 2018-01-03
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.